Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Focal Epilepsy: early-phase trial registry
8 of 9 indexed Focal Epilepsy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 8 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Focal Epilepsy: 9 US clinical trials tracked, 8 recruiting.
Focal Epilepsy is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Biohaven Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition focal-epilepsy
OPEN 8 | RECR 89% | LATE 0 | EARLY 4 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Spinal Cord Injury (89% recruiting · 9 trials)
Focal Epilepsy lists 8 open slots (89% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Focal Epilepsy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Focal Epilepsy is recruiting above its size-band peers.
8 of 9 indexed trials (88.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Focal Epilepsy research.
Biohaven Therapeutics accounts for 2 of 9 trials (22.2%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Focal Epilepsy enrolment sits around 60 participants.
Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.
-
Focal Epilepsy research is mostly interventional.
9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Biohaven Therapeutics
NCT06309966
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Biohaven Therapeutics
NCT06132893
Breathing Rescue for SUDEP Prevention
The University of Texas Health Science Center, Houston
NCT05981755
Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
Wayne State University
NCT04986683
Sleep Architecture & Cognition in Focal Epilepsy
University of California, Davis
NCT05794295
Study of Transcranial Direct Current Stimulation to Treat Epilepsy
Mayo Clinic
NCT05673915
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
Rapport Therapeutics
NCT07219407
Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
Mayo Clinic
NCT07012148
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
Xenon Pharmaceuticals
NCT03796962
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Focal Epilepsy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Focal Epilepsy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Focal Epilepsy page
9 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Focal Epilepsy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Biohaven Therapeutics sponsors the most Focal Epilepsy trials on record, review their full trial history before evaluating a specific study. See Biohaven Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Focal Epilepsy condition card totals 9 registered trials; most-linked intervention BHV-7000; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.